Subscribe
Op-Eds

Shut down the FDA’s failed GLP-1 green list

By Michael Burgess
Published
Add Washington Examiner on Google

People taking GLP-1 drugs deserve to know exactly what is being injected into their bodies.

A new Food and Drug Administration warning letter shows why they may not.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.

Tag:

Bureaucracy China Drugs FDA Medicine Pharmaceutical Industry Weight Loss Drugs